Stent thrombosis and restenosis: what have we learned and where are we going? The Andreas Grüntzig Lecture ESC 2014

Modern-day stenting procedures leverage advances in pharmacotherapy and device innovation. Patients treated with contemporary antiplatelet agents, peri-procedural antithrombin therapy and new-generation drug-eluting stents (DES) have excellent outcomes over the short to medium term. Indeed, coupled...

Descripción completa

Detalles Bibliográficos
Autores principales: Byrne, Robert A., Joner, Michael, Kastrati, Adnan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2015
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4677274/
https://www.ncbi.nlm.nih.gov/pubmed/26417060
http://dx.doi.org/10.1093/eurheartj/ehv511

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4677274/
https://www.ncbi.nlm.nih.gov/pubmed/26417060
http://dx.doi.org/10.1093/eurheartj/ehv511

Ejemplares similares